ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Camila Bragança Xavier

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7203-8011; OpenAlex author ID A5019089659. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical Implications. Co-author DOI 10.1158/1078-0432.ccr-26-0344 ↗
Trametinib and Hydroxychloroquine (HCQ) Combination Treatment in KRAS-Mutated Advanced Pancreatic Adenocarcinoma: Detailed Description of Two Cases. Co-author DOI 10.1007/s12029-020-00556-z ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dan Zhao · 1 shared paper, 2026 · strength 0.26
- Paper Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical Implications. DOI 10.1158/1078-0432.ccr-26-0344 ↗
Jordi Ahnert Rodon · 1 shared paper, 2026 · strength 0.26
- Paper Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical Implications. DOI 10.1158/1078-0432.ccr-26-0344 ↗
David S. Hong · 1 shared paper, 2026 · strength 0.26
- Paper Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical Implications. DOI 10.1158/1078-0432.ccr-26-0344 ↗
Shubham Pant · 1 shared paper, 2026 · strength 0.26
- Paper Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical Implications. DOI 10.1158/1078-0432.ccr-26-0344 ↗
Gustavo dos Santos Fernandes · 1 shared paper, 2021 · strength 0.17
- Paper Trametinib and Hydroxychloroquine (HCQ) Combination Treatment in KRAS-Mutated Advanced Pancreatic Adenocarcinoma: Detai… DOI 10.1007/s12029-020-00556-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.